- Latest weekly return ranks in the strongest part of its sector group.
BOLT
TLV
Week ended 07 Aug 2026
Weekly Investor Report
BioLight Life Sciences Ltd. · Healthcare · Biotechnology
Latest close
3.54 ILA
1.8%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -98.3% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned 1.8%, after a -4.0% four-week move. The latest news-sentiment score is 50/100.
Setup score
16
out of 100
Latest Close
3.54 ILA
7 Aug 2026
1W Return
1.8%
latest completed week
4W Return
-4.0%
short-term follow-through
12W Return
-98.7%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.8%
Latest completed week; four-week move -4.0%.
Indicator stack
0/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.83%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
4 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -98.3% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned 1.8%, after a -4.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.0% over four weeks, -98.7% over 12 weeks, and -99.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.96Latest activity-pressure read.
Pressure change28.3%Four-week change in activity pressure.
Leadership-98.97Latest relative-leadership reading.
RS change0.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 4 relevant articles.
0 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.3%Distance below the 52-week high.
13-week volatility29.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+24.3%Week of 19 Jun.
Worst week-99.1%Week of 5 Jun.
Latest week+1.8%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains7
Flat weeks0
Modest losses4
Sharp losses7
Recent vol29.7%13-week weekly-return volatility.
Base vol16.3%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew6.6% / -10.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIL Healthcare
4-week rank31 / 50
Group average-3.5%
Trend breadth4.0%
Trend4.0%active weekly trend signals
MD20.0%positive activity pressure
RS2.0%positive relative leadership
Four-week leaders
IndustryIL Biotechnology
4-week rank9 / 14
Group average-0.5%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD28.6%positive activity pressure
RS7.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape17/100
Trend, activity pressure, participation, and risk combine to a 17/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Next-Week ExpectancyNegative 39.83%Next-week expectancy is negative with a 39.83% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 4 relevant articles.
BioLight Life Sciences Ltd. Revenue Breakdown – TASE:BOLT Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3.54 ILA | 1.8% | 207.4 ILA | 444.3 ILA | -0.96 | -98.97 | 56.3K | Off |
| 31 Jul 2026 | 3.48 ILA | -17.6% | 219.7 ILA | 448.4 ILA | -1.05 | -99.02 | 88.9K | Off |
| 24 Jul 2026 | 4.22 ILA | 3.8% | 231.6 ILA | 452.5 ILA | -1.18 | -98.89 | 65.2K | Off |
| 17 Jul 2026 | 4.07 ILA | 10.2% | 243.1 ILA | 456.7 ILA | -1.28 | -98.94 | 35.9K | Off |
| 10 Jul 2026 | 3.69 ILA | -8.9% | 255.4 ILA | 460.8 ILA | -1.34 | -99.06 | 61.0K | Off |
| 3 Jul 2026 | 4.05 ILA | 13.6% | 268.0 ILA | 464.9 ILA | -1.45 | -99.02 | 0 | Off |
| 26 Jun 2026 | 3.57 ILA | -2.0% | 278.7 ILA | 469.1 ILA | -1.48 | -99.14 | 0 | Off |
| 19 Jun 2026 | 3.64 ILA | 24.3% | 290.1 ILA | 472.9 ILA | -0.93 | -99.18 | 12.7K | Off |
| 12 Jun 2026 | 2.93 ILA | 0.9% | 302.7 ILA | 477.1 ILA | -0.34 | -99.39 | 9.8K | Off |
| 5 Jun 2026 | 2.90 ILA | -99.1% | 315.9 ILA | 480.8 ILA | -0.07 | -99.40 | 8.8K | Off |
| 29 May 2026 | 335.6 ILA | 6.1% | 329.2 ILA | 484.7 ILA | 0.09 | -36.09 | 46.8K | Off |
| 22 May 2026 | 316.3 ILA | 19.4% | 331.3 ILA | 486.3 ILA | -0.40 | -40.03 | 248.3K | Off |
| 15 May 2026 | 265.0 ILA | 6.0% | 334.6 ILA | 488.0 ILA | -0.77 | -50.74 | 67.9K | Off |
| 8 May 2026 | 250.1 ILA | 4.8% | 340.1 ILA | 489.9 ILA | -0.96 | -55.87 | 145.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.